These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 5781329)

  • 1. [Inhibiting effects of Xylamide on induced maximal gastric acid secretion in humans].
    Sampietro R
    Minerva Med; 1969 Mar; 60(23):1032-7. PubMed ID: 5781329
    [No Abstract]   [Full Text] [Related]  

  • 2. [Study of gastric secretory function and its inhibition with Xylamide. The maximal acid output (MAO) test and the Hollander test].
    Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
    Minerva Med; 1969 Mar; 60(23):1063-9. PubMed ID: 5781334
    [No Abstract]   [Full Text] [Related]  

  • 3. [Clinical study of a new anti-ulcer drug: CR-242, Xylamide, in 23 cases].
    Uzeta Mejia S
    Minerva Med; 1969 Mar; 60(23):1070-3. PubMed ID: 5781335
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic activity in gastric and duodenal ulcers, gastritis and gastroduodenitis of an anti-secretory, non-anticholinergic drug].
    Bianchi PG; Saccabusi E
    Minerva Med; 1969 Mar; 60(23):1044-52. PubMed ID: 5781331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Therapy of gastro-duodenal ulcer, gastritis and gastroduodenitis with an antisecretory, non-anticholinergic drug (Milid)].
    Borellini D; Milvio C
    Minerva Med; 1969 Mar; 60(23):1053-6. PubMed ID: 5781332
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical experiences with CR-242, Xylamide, in the treatment of gastroduodenal ulcerous disease. Study of 30 cases].
    Arias Vallejo E; Diaz G; Moreno Arranz B; Lozano L
    Minerva Med; 1969 Mar; 60(23):1057-62. PubMed ID: 5781333
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological studies on an antigastrin and antiulcer agent, SC-15396.
    Bianchi RG; Cook DL
    Fed Proc; 1968; 27(6):1331-6. PubMed ID: 5725225
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of Xylamide (MILID) as an antisecretory-antigastrinic agent in acute pancreatitis].
    Margnelli M; Zacco R; Velati GF
    Minerva Gastroenterol; 1969; 15(4):229-34. PubMed ID: 5379889
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical trials of a pharmacological perparation in the therapy of ulcerous gastroduodenitis].
    Linati E
    Minerva Med; 1969 Mar; 60(23):1038-43. PubMed ID: 5781330
    [No Abstract]   [Full Text] [Related]  

  • 10. [Evaluation of the therapeutic activity of CR 242 or Xylamide in the treatment of gastric and duodenal ulcers and of gastroduodenitis].
    Bellomo A; Strobbia R; Manzoni A
    Minerva Med; 1969 Mar; 60(23):1024-31. PubMed ID: 5781328
    [No Abstract]   [Full Text] [Related]  

  • 11. Inhibition of gastric acid secretion in man by peptide analogues of cholecystokinin.
    Brooks AM; Agosti A; Bertaccini G; Grossman MI
    N Engl J Med; 1970 Mar; 282(10):535-8. PubMed ID: 5460986
    [No Abstract]   [Full Text] [Related]  

  • 12. [Evaluation of the antigastrin effect of xilamide].
    Laudano OM
    Prensa Med Argent; 1968 Nov; 55(40):1896-8. PubMed ID: 5714058
    [No Abstract]   [Full Text] [Related]  

  • 13. [Relations between the chemical structure and antigastrin activity in the rat of a new derivative of a dicarboxylic amino acid].
    Rovati AL
    Minerva Med; 1969 Mar; 60(23):1011-6. PubMed ID: 5781326
    [No Abstract]   [Full Text] [Related]  

  • 14. [Xylamide (Milid) therapy of gastroduodenitis in patients with saturnism].
    Gambini G; Grisler R
    Minerva Med; 1969 Mar; 60(23):1017-23. PubMed ID: 5781327
    [No Abstract]   [Full Text] [Related]  

  • 15. [Preliminary studies of the effects of xylamide on gastric secretion induced with caerulein].
    Mantovani P; Piccinin GL; Romano A
    Boll Soc Ital Biol Sper; 1970 Mar; 46(6):279-81. PubMed ID: 5458653
    [No Abstract]   [Full Text] [Related]  

  • 16. [Pentagastrin as a stimulant of maximum gastric secretion in man].
    Laudano OM
    Rev Esp Enferm Apar Dig; 1968 Apr; 27(4):544-9. PubMed ID: 5670665
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of caerulein on histamine and pentagastrin-induced gastric secretion in man.
    Konturek SJ; Gabryś B
    Am J Dig Dis; 1970 Sep; 15(9):791-5. PubMed ID: 5459739
    [No Abstract]   [Full Text] [Related]  

  • 18. [Activity-structure relationship in compounds with antigastrin activity].
    Andrási F; Borsy J; Farkas L
    Acta Pharm Hung; 1973 Jul; 43(3):116-20. PubMed ID: 4747707
    [No Abstract]   [Full Text] [Related]  

  • 19. Antigastrin suppression of gastrin, histamine, and vagal gastric secretion.
    Tiongco R; Isaza J; Sugawara K; Eisenberg MM
    Surg Forum; 1968; 19():280-2. PubMed ID: 5718630
    [No Abstract]   [Full Text] [Related]  

  • 20. [Heparin inhibition of peptic acid secretion. Clinical study].
    Cavina E; Caldarelli G; Falaschi M
    Osp Ital Chir; 1967 Dec; 17(6):679-88. PubMed ID: 5607768
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.